Reunert OCF Margin
The Operating Cash Flow Margin of Reunert (RLO.JO) as of Jul 25, 2026 is 4.87 %. In the previous year, Operating Cash Flow Margin was 5.34 % — a change of -8.84% (lower).
Get this data via API
Financial Data API
OCF Margin
4.87 %
YoY
-8.84%
Last updated:
Operating Cash Flow Margin of Reunert is 2026 4.87 % . Operating Cash Flow Margin of Reunert was 2025 5.34 % . It decreases by -8.84% lower compared to the previous year.
Access this data via the Eulerpool API
Reunert Stock analysis
What does Reunert do? Reunert Ltd is a South African company that has been playing an important role in various industries for over 125 years. The company's history dates back to 1888 when Theodore Reunert founded the company in Johannesburg. Initially, Reunert traded in electrical equipment and soon after established its own production.
Today, Reunert is a leading provider of electronics, communication technology, and information technology in South Africa. The company is divided into various divisions, including electronics, consumer products, information technology, and medical systems. Each business area focuses on different products, solutions, and services.
Reunert's electronics division includes various components and devices, including switches and sensors, printed circuit boards, and wireless communication systems. The company also has advanced manufacturing capabilities to design and manufacture customized products and solutions.
Reunert's consumer products are focused on the sale and marketing of white goods and household items such as refrigerators, washing machines, dryers, vacuum cleaners, and kettles. The company collaborates with various high-end brands to offer a wide range of products.
Reunert's IT division provides a variety of solutions, including network infrastructure, knowledge management integration, software systems, and professional services. The company has also made significant investments in cybersecurity and offers customers a comprehensive range of services to protect their network security and integrity.
Reunert's medical systems offer state-of-the-art medical technology, including ultrasound devices, medical imaging systems, medical information systems, and urological devices. The department specializes in translating modern technology and medical expertise into evidence-based practice to improve quality of life.
The future of Reunert is characterized by growth and innovation. The company continuously works to improve its products and services to meet the constantly changing demands of its customers. Through collaboration with other companies and the acquisition of technology companies, Reunert is driving its expansion into new markets.
Overall, Reunert has established itself as one of the leading electronics and IT companies in South Africa. Through diversification of its business areas and the development of innovative products and services, the company will continue to focus on growth and success. Reunert is one of the most popular companies on Eulerpool.
Frequently Asked Questions about Reunert stock
Operating Cash Flow Margin of Reunert is 4.87 % in 2026.
Access this data via the Eulerpool API
Margins — Reunert
All Key Metrics — Reunert
Valuation
Income Statement
Margins
Balance Sheet
- Total Assets
- Current Assets
- Cash & Equivalents
- Receivables
- Inventory
- Property, Plant & Equipment
- Goodwill
- Intangible Assets
- Equity
- Liabilities
- Debt
- Current Liabilities
- Long-term Debt
- Short-term Debt
- Retained Earnings
- Book Value per Share
- Tangible Book Value per Share
- Working Capital
- Investments
- Accounts Payable
- Non-Current Assets
- Short-Term Investments
- Long-Term Investments
- Net Debt
- Treasury Stock
- Minority Interest
- Deferred Tax Liabilities
- Net Tangible Assets
- Goodwill/Assets
- Intangibles/Assets
Cash Flow
- Operating Cash Flow
- Capital Expenditures
- Free Cash Flow
- FCF per Share
- Dividends Paid
- Share Buybacks
- Investing Cash Flow
- Financing Cash Flow
- CapEx / Revenue
- Cash Flow per Share
- Stock-Based Compensation
- Change in Working Capital
- Acquisitions (Net)
- Net Change in Cash
- CapEx/OCF
- FCF/Net Income
- FCF Conversion
- Cash Conversion
- Total Shareholder Payout
- CapEx/D&A
Profitability
- ROE
- ROA
- ROCE
- ROIC
- Asset Turnover
- Inventory Turnover
- Receivables Turnover
- Days Sales Outstanding
- Days Inventory Outstanding
- Days Payable Outstanding
- Cash Conversion Cycle
- CROIC
- Gross Profit/Assets
- Fixed Asset Turnover
- Equity Turnover
- Working Capital Turnover
- Payables Turnover
- Capital Intensity
- Receivables/Revenue
- Inventory/Revenue
- EBIT/Assets
Leverage
Growth
- Revenue Growth
- Revenue CAGR 3Y
- Revenue CAGR 5Y
- Revenue CAGR 10Y
- Earnings Growth
- EPS Growth
- EBIT Growth
- EBIT CAGR 3Y
- EBIT CAGR 5Y
- EBIT CAGR 10Y
- Dividend Growth
- FCF Growth
- Book Value Growth
- Earnings CAGR 3Y
- Earnings CAGR 5Y
- Earnings CAGR 10Y
- EPS CAGR 3Y
- EPS CAGR 5Y
- EBITDA Growth YoY
- EBITDA CAGR 3Y
- EBITDA CAGR 5Y
- Gross Profit Growth
- OCF Growth YoY
- Employee Growth
- Dividend CAGR 3Y
- Dividend CAGR 5Y
- Dividend CAGR 10Y
- Asset Growth
- Equity Growth
- Debt Growth
- CapEx Growth
- FCF CAGR 3Y
- FCF CAGR 5Y
- Market Cap Growth
- Share Count Growth